Article Details
Retrieved on: 2021-08-02 13:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(XCUR) announced today that the clinical-stage biotechnology firm has just signed an exclusive collaboration deal with Ipsen to “research, develop, and ...
Article found on: www.investorsobserver.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here